(Q36573859)

15 August 2017

1 reference

title

Controversial issues and optimal management of stage T1G3 bladder cancer (English)

1 reference

15 August 2017

Adam R Metwalli

1

1 reference

PubMed ID

16925494

15 August 2017

Ashish M Kamat

series ordinal

2

1 reference

15 August 2017

1 August 2006

1 reference

Expert Review of Anticancer Therapy

15 August 2017

1 reference

15 August 2017

6

1 reference

15 August 2017

1283-1294

1 reference

15 August 2017

8

1 reference

15 August 2017

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Optimal management of the T1G3 bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Do patients profit from 5-aminolevulinic acid-induced fluorescence diagnosis in transurethral resection of bladder carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: A new proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Intravesical bacille Calmette-Guérin in Stage T1 grade 3 bladder cancer therapy: a 7-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Clinical outcome of conservative therapy for stage T1, grade 3 transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

If cystectomy is insufficient, what is an urologist to do?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Micropapillary carcinoma of the bladder: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

[Primary sarcomatoid carcinoma of the ureter]

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 12 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

The nested variant of transitional cell carcinoma--a rare neoplasm with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Pretreatment p53 nuclear overexpression as a prognostic marker in superficial bladder cancer treated with Bacillus Calmette-Guérin (BCG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Transurethral resection and sequential chemo-immunoprophylaxis in primary T1G3 bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Recurrence and progression in stage T1G3 bladder tumour with intravesical bacille Calmette-Guérin (Danish 1331 strain).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Radiotherapy is an effective treatment for high-risk T1-bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Photodynamic therapy for refractory superficial bladder cancer: long-term clinical outcomes of single treatment using intravesical diffusion medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral kock pouch

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

The treated natural history of high risk superficial bladder cancer: 15-year outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Predicting the survival of bladder carcinoma patients treated with radical cystectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

T1G3 bladder cancer--indications for early cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

T1G3 bladder tumours: the case for radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

FGFR3 and Tp53 Mutations in T1G3 Transitional Bladder Carcinomas: Independent Distribution and Lack of Association with Prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

Preliminary European Results of Local Microwave Hyperthermia and Chemotherapy Treatment in Intermediate or High Risk Superficial Transitional Cell Carcinoma of the Bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1283

10.1586/14737140.6.8.1283

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

16925494